Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study. (Q51843450)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 2006

Language	Label	Description	Also known as
English	Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.	scientific article published in January 2006

Statements

scholarly article

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study. (English)

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

1 reference

based on heuristic

inferred from title

major depressive episode

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

4

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

author name string

Itsuro Ida

2

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Toshimi Owashi

3

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Yumiko Inoue

5

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Shin Nakagawa

6

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Takafumi Yabana

7

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Takako Urushibara

8

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Rie Kanai

9

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Masako Aihara

10

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Naoya Yuuki

11

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Tempei Otsubo

12

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Akihiko Oshima

13

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Koutaro Kudo

14

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Takeshi Inoue

15

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Yuji Kitaichi

16

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Osamu Shirakawa

17

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Koichi Isogawa

18

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Haruo Nagayama

19

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Kunitoshi Kamijima

20

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Shinichiro Nanko

21

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Shigenobu Kanba

22

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Teruhiko Higuchi

23

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Masahiko Mikuni

24

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

language of work or name

0 references

publication date

1 January 2006

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

Neuropsychopharmacology

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

31

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

1

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

212-220

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300868

0 references

Plasma pattern of adrenocorticotropin and cortisol during electroconvulsive therapy in patients with major depressive illness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Evaluation of a salivary based combined dexamethasone/CRH test in patients with major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

The dexamethasone suppression test for melancholia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Are serial dexamethasone suppression tests useful in electroconvulsive therapy?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Pulse-dosing and conventional application of doxepin: effects on psychopathology and hypothalamus-pituitary-adrenal (HPA) system.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Serial dexamethasone suppression tests and plasma dexamethasone levels. Effects of clinical response to electroconvulsive therapy in major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Clinical outcome after trimipramine in patients with delusional depression - a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Serial dexamethasone suppression tests in depressed patients treated only with electroconvulsive therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

The combined DEX-CRH test in treatment course and long-term outcome of major depression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Combined dexamethasone/CRH test in rats: hypothalamo-pituitary-adrenocortical system alterations in aging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of gender.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

The Munich vulnerability study on affective disorders: premorbid neuroendocrine profile of affected high-risk probands

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Combined DEX/CRH test among Japanese patients with major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Decreased in vitro sensitivity to dexamethasone in corticotropes from middle-age rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients pretreated with dexamethasone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Hypothalamic-pituitary-adrenal axis function in patients with chronic depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

21 January 2018

The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

7 January 2021

based on heuristic

inferred from DOI database lookup

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial dexamethasone suppression tests in initial suppressors and nonsuppressors treated with electroconvulsive therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

7 January 2021

based on heuristic

inferred from DOI database lookup

Endogenous vasopressin contributes to hypothalamic-pituitary-adrenocortical alterations in aged rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

7 January 2021

based on heuristic

inferred from DOI database lookup

Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

7 January 2021

based on heuristic

inferred from DOI database lookup

Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

7 January 2021

based on heuristic

inferred from DOI database lookup

Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

7 January 2021

based on heuristic

inferred from DOI database lookup

The differential ACTH responses to combined dexamethasone/CRH administration in major depressive and dysthymic disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroendocrine measures in psychiatric patients: course and outcome with ECT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

7 January 2021

based on heuristic

inferred from DOI database lookup

Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300868

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1300868

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16123748

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51843450&oldid=1509911960"